Marathon inflammation faded by 48 hours in runners

A marathon triggers a robust systemic inflammatory response, and most endurance recovery nutrition advice focuses on what runners eat immediately around a race rather than on the fat composition of the diet in the months before it. Whether habitual dietary fat quality shifts baseline cytokine concentrations, or changes how big the post-race inflammatory spike is and how quickly it settles, was not known. This exploratory study set out to see whether such a link is detectable at all in ordinary recreational runners, using a detailed breakdown of fat types rather than simply total fat intake.

Thirty-one recreational marathon runners, 58.1% of them female with a mean age of 38.4 ± 10.2 years, completed the Diet History Questionnaire III covering habitual fat intake over the preceding three months, broken down into chain-length-specific saturated, monounsaturated and polyunsaturated fatty acids, trans fatty acids and CLA. Blood was collected at three time points: before the race, immediately after finishing, and 48 h later. IFN-γ, IL-1β, IL-4, IL-6, IL-10 and TNF-α were measured at each point. Repeated measures ANOVA tracked the cytokine time course, and multivariable regression adjusted for 11 pre-specified covariates tested fat–cytokine associations, with Benjamini-Hochberg correction applied across all models.

IL-6 rose markedly immediately after the race (p < 0.001, generalized η2 = 0.615) and had returned to pre-race concentrations by 48 h. The anti-inflammatory cytokine IL-10 followed a similar rise-and-return trajectory (p < 0.001, generalized η2 = 0.346). TNF-α showed only a borderline non-significant trend (p = 0.056), and IFN-γ, IL-1β and IL-4 did not change significantly at any point. Of all the fat types examined, only the long-chain monounsaturated fatty acid 20:1 survived correction for multiple testing: it was positively associated with IFN-γ (β = 13.66) and with TNF-α (β = 9.14) at 48 h post-race, and not at earlier time points.

That IL-6 surges after prolonged endurance work and then subsides is consistent with the established picture of exercise-induced inflammation, and this study adds a concrete timeline showing the return to baseline within two days in recreational runners. The novel and much more tentative part is the dietary signal, which appeared only in the later recovery window once the acute exercise-driven signalling had faded. The authors interpret that timing as suggesting the 48 h phase may be when habitual fat quality is most visible in circulating cytokines. Whether the 20:1 association is causal, a marker of some broader dietary pattern, or a chance finding among many comparisons remains entirely open.

The clearest takeaway is descriptive: the inflammatory surge from a marathon, at least as measured by these cytokines, appears to be short-lived rather than lingering for days. The dietary part is a hypothesis, not guidance — a single association between one specific long-chain monounsaturated fat and two cytokines in a small exploratory sample is not a reason to change how you eat, and higher cytokine readings at 48 h were not linked to any symptom, performance or health outcome here. It is a reason to think habitual fat quality is worth studying properly in endurance recovery research, nothing more.